Computational biology superstar Sanju Sinha joins Sanford Burnham Prebys

Sanju Sinha, Ph.D., has joined Sanford Burnham Prebys from the Cancer Data Science Lab at the National Cancer Institute (NCI), where he trained to leverage the power of artificial intelligence to discover new drugs to prevent cancer.

“A key reason I chose to come here is the Institute’s strong track record of research on the biology of aging,” says Sinha. “Sanford Burnham Prebys also does world-class drug discovery research, and I want to work in the intersection of these two areas to develop therapeutic interventions that can stop cancer before it begins.”

Read more >>

Pumping the brakes on autoimmune disease

A new study describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial

The collaboration with Eli Lilly and Company revealed the structure and function of a drug called LY3361237, which may help treat lupus, an autoimmune disease affecting multiple organs in the body. 

“It’s miraculous that we can change the activity of the immune system with drugs, but we’re still at an incredibly early stage in terms of figuring out how this works,” says Professor Carl Ware, Ph.D. 

Read more >>

Katya Marchetti selected for prestigious Women in Science scholarship

The Association for Women in Science award encourages outstanding women pursuing degrees in STEM fields at San Diego colleges and universities.

Marchetti is a graduate student who will use the funds to support her research on hypoplastic left heart syndrome, a congenital disease that is nearly always fatal without heart surgery. After finishing her Ph.D., her long-term goal is to continue working in the San Diego research community. 

Read more >>

Researchers awarded Curebound grants

Each year, Sanford Burnham Prebys joins Padres Pedal the Cause, an annual fundraising event that raises money for Curebound, which awards collaborative cancer grants in the San Diego area.

These grants include Discovery Grants, which provide seed funds for high-risk/high-reward research in the earliest phases, and Targeted Grants, which are larger awards ($500K) that help translate promising discoveries into treatments for the clinic.

Read more >>

Opinion: Including researchers of diverse backgrounds makes science more accurate and applicable

Historically, scientific and clinical studies have addressed research and health questions primarily through the prism of White males.

Read more >>

Is San Diego’s rooftop solar boom over? Not at Sanford Burnham Prebys

Many in the county are facing barriers to adopting solar energy, but Sanford Burnham Prebys is leading the charge with a $2.5 million investment in solar power.

Read more >>

You believe in discovery – and progress

... and you make it happen!

More people than ever are surviving cancer. Diseases that used to be considered death sentences have been eradicated. Every day, new treatments and new cures are being discovered...

It’s all because people like you said YES to discovery.

You see “incurable” diseases and “unsolvable” health problems ... and you say, “I believe we can change that!”

The research you’re reading about in this newsletter begins with forward-looking, optimistic people like you. Your giving plants the seeds that grow into change, cures, and a better world for everyone.

There’s still a long way to go. Problems to solve. Diseases that destroy lives.

But we’re making progress. And you help make it happen!

Please think about donating today to push forward transformational research here at Sanford Burnham Prebys.

Thank you for making progress possible!

Christine Sanchez Dittmer

Chief Development Officer

Do you have any questions about your giving? Please call me directly at: (714) 244-6250